- Socioeconomic Factors Are Associated With Disparities in Germline Testing in Pancreatic Cancer.
- King D, Scott R.
- OncLive. 2023 Feb 5.
- Conference report, Interview
- Free Full Text
- Mitigating fear of cancer recurrence.
- Sorscher S.
- Breast Cancer Res Treat. 2023 Feb 3. doi: 10.1007/s10549-022-06824-9. Epub ahead of print.
- PMID: 36737585
- PubMed abstract
- Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice.
- Yamai T, Ikezawa K, Sugimoto N, Urabe M, Kai Y, Takada R, Nakabori T, Uehara H, Kawamura T, Kunimasa K, Yamamoto S, Wakamatsu T, Hayashi T, Kukita Y, Fujisawa F, Inoue T, Yamaguchi Y, Yamasaki T, Honma K, Ohkawa K.
- Cancers (Basel). 2023 Feb 3;15(3):970. doi: 10.3390/cancers15030970.
- Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review.
- Chatterji S, Krzoska E, Thoroughgood CW, Saganty J, Liu P, Elsberger B, Abu-Eid R, Speirs V.
- Lancet Oncol. 2023 Feb;24(2):e74-e85. doi: 10.1016/S1470-2045(22)00633-7.
- PMID: 36725152
- PubMed abstract
- Source abstract
- Review
•• Podcast:
In conversation with... Valerie Speirs.
- Validation of multi-gene panel next-generation sequencing for the detection of BRCA mutation in formalin-fixed, paraffin-embedded epithelial ovarian cancer tissues.
- Kim ET, Jeong HE, Yoon HJ, Kim KH, Suh DS.
- Taiwan J Obstet Gynecol. 2023 Jan;62(1):66-70. doi: 10.1016/j.tjog.2022.07.010.
- PMID: 36720553
- PubMed abstract